You are here:

Forthcoming Submissions:

PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Non-PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
5-aminolevulinic acid hydrochloride (Ameluz) Biofrontera Bioscience GmbH Full submission 5/06/2017 4/07/2017 7/08/2017
adalimumab (Humira) AbbVie Ltd Abbreviated Submission N/A 2/05/2017 12/06/2017

Medicines with advice withheld pending product availability

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Back